Resultats de la cerca - André Scheen

Refinar resultats
  1. 1
    Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus

    Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus per André Scheen

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia

    Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia per André Scheen

    Publicat 2010
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes

    Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes per André Scheen

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

    Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease per André Scheen

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Drug–Drug Interactions with Sodium-Glucose Cotransporters Type 2 (SGLT2) Inhibitors, New Oral Glucose-Lowering Agents for the Management of Type 2 Diabetes Mellitus

    Drug–Drug Interactions with Sodium-Glucose Cotransporters Type 2 (SGLT2) Inhibitors, New Oral Glucose-Lowering Agents for the Management of Type 2 Diabetes Mellitus per André Scheen

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials

    DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials per André Scheen

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

    Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor per André Scheen

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?

    Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? per André Scheen

    Publicat 2005
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease

    Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease per André Scheen

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Sibutramine on Cardiovascular Outcome

    Sibutramine on Cardiovascular Outcome per André Scheen

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    A review of gliptins in 2011

    A review of gliptins in 2011 per André Scheen

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

    Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease per André Scheen

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

    DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects per André Scheen

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME

    Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME per André Scheen

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    GLP-1 receptor agonists and heart failure in diabetes

    GLP-1 receptor agonists and heart failure in diabetes per André Scheen

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Cardiovascular Effects of New Oral Glucose-Lowering Agents

    Cardiovascular Effects of New Oral Glucose-Lowering Agents per André Scheen

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Metformin and COVID-19: From cellular mechanisms to reduced mortality

    Metformin and COVID-19: From cellular mechanisms to reduced mortality per André Scheen

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  18. 18
    DPP-4 inhibition and COVID-19: From initial concerns to recent expectations

    DPP-4 inhibition and COVID-19: From initial concerns to recent expectations per André Scheen

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies

    Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies per André Scheen

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Obesity and liver disease

    Obesity and liver disease per André Scheen, Françoise Luyckx

    Publicat 2002
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: